Market News AIOpen the app

BCRX stock news · BioCryst Pharmaceuticals Inc.

Stories about BioCryst Pharmaceuticals Inc. (BCRX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BCRX

Follow BioCryst Pharmaceuticals Inc. (BCRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BCRX
Free on the App Store and Google Play, or on the web.
  1. Oct 23, 2026, 2:18 PM ET · Opinion

    An analyst thinks Pharvaris is a good choice now that worries about its drug are lessening.

    Neutral

    BioCryst’s Orladeyo is named as a competing treatment, but the report says switching from it may be limited. It gives no new sales or trial result for BioCryst, so this story does not change its outlook.